Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013.
Saved in:
| Title: | Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013. |
|---|---|
| Authors: | Hasin, Deborah S. (AUTHOR), Mannes, Zachary L. (AUTHOR), Livne, Ofir (AUTHOR), Fink, David S. (AUTHOR), Martins, Silvia S. (AUTHOR), Stohl, Malki (AUTHOR), Olfson, Mark (AUTHOR), Cerdá, Magdalena (AUTHOR), Keyes, Katherine M. (AUTHOR), Keyhani, Salomeh (AUTHOR), Wisell, Caroline G. (AUTHOR), Bujno, Julia M. (AUTHOR), Saxon, Andrew (AUTHOR) |
| Source: | Substance Use & Misuse. 2025, Vol. 60 Issue 2, p285-292. 8p. |
| Subjects: | Substance abuse, Research funding, Mental illness, Logistic regression analysis, United States. Dept. of Veterans Affairs, Interviewing, Affective disorders, Anxiety, Surveys, Cannabis (Genus), Confidence intervals, Antisocial personality disorders, Adults |
| Geographic Terms: | United States |
| Abstract: | Background: Rates of cannabis use disorder (CUD) have increased disproportionately among Veterans Administration (VA) patients with psychiatric disorders compared to patients with no disorder. However, VA patient samples are not representative of all U.S. adults, so results on disproportionate increases in CUD prevalence could have been biased. To address this concern, we investigated whether disproportionate increases in the prevalence of cannabis outcomes among those with psychiatric disorders would replicate in nationally representative samples of U.S. adults. Methods: Data came from two national surveys conducted in 2001-2002 (n = 43,093) and 2012-2013 (n = 36,309). Outcomes were any past-year non-medical cannabis use, frequent non-medical use (≥3 times weekly), and DSM-IV CUD. Psychiatric disorders included mood, anxiety and antisocial personality disorders. Logistic regression was used to generate predicted prevalences of the outcomes, prevalence differences calculated and additive interactions compared differences between those with and without psychiatric disorders. Results: Cannabis outcomes increased more among those with psychiatric disorders. The difference in prevalence differences included any past-year non-medical cannabis use, 2.45% (95%CI = 1.29-3.62); frequent non-medical cannabis use, 1.58% (95%CI = 0.83-2.33); CUD, 1.40% (95%CI = 0.58-2.21). For most specific disorders, prevalences increased more among those with the disorder. Conclusions: In the U.S. general population, rates of cannabis use and CUD increased more among adults with psychiatric disorders than other adults, similar to findings from VA patient samples. Results suggest that although VA patients are not representative of all U.S. adults, findings from this important patient group can be informative. Greater clinical and policy attention to CUD is warranted for adults with psychiatric disorders. [ABSTRACT FROM AUTHOR] |
| Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 182160466 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hasin%2C+Deborah+S%2E%22">Hasin, Deborah S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mannes%2C+Zachary+L%2E%22">Mannes, Zachary L.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Livne%2C+Ofir%22">Livne, Ofir</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fink%2C+David+S%2E%22">Fink, David S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martins%2C+Silvia+S%2E%22">Martins, Silvia S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stohl%2C+Malki%22">Stohl, Malki</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Olfson%2C+Mark%22">Olfson, Mark</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cerdá%2C+Magdalena%22">Cerdá, Magdalena</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keyes%2C+Katherine+M%2E%22">Keyes, Katherine M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keyhani%2C+Salomeh%22">Keyhani, Salomeh</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wisell%2C+Caroline+G%2E%22">Wisell, Caroline G.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bujno%2C+Julia+M%2E%22">Bujno, Julia M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saxon%2C+Andrew%22">Saxon, Andrew</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Substance+Use+%26+Misuse%22">Substance Use & Misuse</searchLink>. 2025, Vol. 60 Issue 2, p285-292. 8p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Substance+abuse%22">Substance abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+illness%22">Mental illness</searchLink><br /><searchLink fieldCode="DE" term="%22Logistic+regression+analysis%22">Logistic regression analysis</searchLink><br /><searchLink fieldCode="DE" term="%22United+States%2E+Dept%2E+of+Veterans+Affairs%22">United States. Dept. of Veterans Affairs</searchLink><br /><searchLink fieldCode="DE" term="%22Interviewing%22">Interviewing</searchLink><br /><searchLink fieldCode="DE" term="%22Affective+disorders%22">Affective disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Anxiety%22">Anxiety</searchLink><br /><searchLink fieldCode="DE" term="%22Surveys%22">Surveys</searchLink><br /><searchLink fieldCode="DE" term="%22Cannabis+%28Genus%29%22">Cannabis (Genus)</searchLink><br /><searchLink fieldCode="DE" term="%22Confidence+intervals%22">Confidence intervals</searchLink><br /><searchLink fieldCode="DE" term="%22Antisocial+personality+disorders%22">Antisocial personality disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Adults%22">Adults</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22United+States%22">United States</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background: Rates of cannabis use disorder (CUD) have increased disproportionately among Veterans Administration (VA) patients with psychiatric disorders compared to patients with no disorder. However, VA patient samples are not representative of all U.S. adults, so results on disproportionate increases in CUD prevalence could have been biased. To address this concern, we investigated whether disproportionate increases in the prevalence of cannabis outcomes among those with psychiatric disorders would replicate in nationally representative samples of U.S. adults. Methods: Data came from two national surveys conducted in 2001-2002 (n = 43,093) and 2012-2013 (n = 36,309). Outcomes were any past-year non-medical cannabis use, frequent non-medical use (≥3 times weekly), and DSM-IV CUD. Psychiatric disorders included mood, anxiety and antisocial personality disorders. Logistic regression was used to generate predicted prevalences of the outcomes, prevalence differences calculated and additive interactions compared differences between those with and without psychiatric disorders. Results: Cannabis outcomes increased more among those with psychiatric disorders. The difference in prevalence differences included any past-year non-medical cannabis use, 2.45% (95%CI = 1.29-3.62); frequent non-medical cannabis use, 1.58% (95%CI = 0.83-2.33); CUD, 1.40% (95%CI = 0.58-2.21). For most specific disorders, prevalences increased more among those with the disorder. Conclusions: In the U.S. general population, rates of cannabis use and CUD increased more among adults with psychiatric disorders than other adults, similar to findings from VA patient samples. Results suggest that although VA patients are not representative of all U.S. adults, findings from this important patient group can be informative. Greater clinical and policy attention to CUD is warranted for adults with psychiatric disorders. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=182160466 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10826084.2024.2423374 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 285 Subjects: – SubjectFull: Substance abuse Type: general – SubjectFull: Research funding Type: general – SubjectFull: Mental illness Type: general – SubjectFull: Logistic regression analysis Type: general – SubjectFull: United States. Dept. of Veterans Affairs Type: general – SubjectFull: Interviewing Type: general – SubjectFull: Affective disorders Type: general – SubjectFull: Anxiety Type: general – SubjectFull: Surveys Type: general – SubjectFull: Cannabis (Genus) Type: general – SubjectFull: Confidence intervals Type: general – SubjectFull: Antisocial personality disorders Type: general – SubjectFull: Adults Type: general – SubjectFull: United States Type: general Titles: – TitleFull: Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hasin, Deborah S. – PersonEntity: Name: NameFull: Mannes, Zachary L. – PersonEntity: Name: NameFull: Livne, Ofir – PersonEntity: Name: NameFull: Fink, David S. – PersonEntity: Name: NameFull: Martins, Silvia S. – PersonEntity: Name: NameFull: Stohl, Malki – PersonEntity: Name: NameFull: Olfson, Mark – PersonEntity: Name: NameFull: Cerdá, Magdalena – PersonEntity: Name: NameFull: Keyes, Katherine M. – PersonEntity: Name: NameFull: Keyhani, Salomeh – PersonEntity: Name: NameFull: Wisell, Caroline G. – PersonEntity: Name: NameFull: Bujno, Julia M. – PersonEntity: Name: NameFull: Saxon, Andrew IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 10826084 Numbering: – Type: volume Value: 60 – Type: issue Value: 2 Titles: – TitleFull: Substance Use & Misuse Type: main |
| ResultId | 1 |